Carboxymethyl-dextran-gadolinium-DTPA as a blood-pool contrast agent for magnetic resonance angiography: Experimental study in rabbits

Investigative Radiology

Volumn 31, Issue 5, 1996, Pages 288-293

  Loubeyre, Pierre ^a   Canet, Emmanuelle ^a   Zhao, Shihua ^a   Benderbous, Soraya ^b   Amiel, Michel ^a   Revel, Didier ^a,c  

^a Lab de Radiol Exp   (France)

^b Laboratoire Guerbet   (France)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

experimental study; macromolecular contrast agent; Magnetic resonance angiography; time of flight

Indexed keywords

CARBOXYMETHYLDEXTRAN GADOLINIUM PENTETATE; CONTRAST MEDIUM; GADOLINIUM PENTETATE DERIVATIVE; GADOTERIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AORTA; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RENAL ARTERY; SIGNAL NOISE RATIO; VEIN;

EID: 0029969551     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199605000-00008     Document Type: Article

References (21)

1. Atkinson D, Brant-Zawadzki M, Gillan G, Purdy D, Laub G. Improved MR angiography: Magnetization transfer suppression with variable flip angle excitation and increased resolution. Radiology 1994;190:890-894.
2. Hendrick RE, Haacke EM. Basic physics of MR contrast agents and maximization of image contrast. J Magn Reson Imaging 1993;3:137-148.
3. Price RR, Creasy JL, Lorentz CH, Partain CL. Magnetic resonance angiography techniques. Invest Radiol 1992;27:S27-S32.
4. Creasy JL, Price RR, Presbey T, Goins D, Partain CL, Kessler RM. Gadolinium-enhanced MR angiography. Radiology 1990;175: 280-283.
5. Lin W, Haacke EM, Smith AS, Clampitt ME. Gadolinium-enhanced high-resolution MR angiography with adaptive vessel tracking: Preliminary results in the intracranial circulation. J Magn Reson Imaging 1992;2:277-284.
6. Brasch RC. New directions in the development of MR imaging contrast media. Radiology 1992;183:1-11.
7. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G. Superparamagnetic iron oxides as a positive MR contrast agent: In vitro and in vivo evidence. Magn Reson Imaging 1993;11:509-519.
8. Frank H, weissleder R, Brady T.J. Enhancement of MR angiography with iron oxide: Preliminary studies in whole-blood phantom and in animals. AJR Am J Roentgenol 1994;162:209-213.
9. Bogdanov AA, Weissleder R, Frank HW, et al. A new macromolecule as a contrast agent for MR angiography: Preparation, properties, and animal studies. Radiology 1993;187:701-706.
10. Marchal G, Bosmans H, Van Hecke P, Jiang Y, Aerts P, Bauer H. Experimental Gd-DTPA polylysine enhanced MR angiography: Sequence optimization. J Comput Assist Tomogr 1991;15: 711-715.
11. Marchal G, Bosmans H, Van Hecke P, et al. MR angiography with Gadopentetate dimeglumine polylysine: Evaluation in rabbits. AJR Am J Roentgenol 1990;155:407-411.
12. Moseley ME, White DL, Wang JC, et al. Vascular mapping using albumin-(Gd-DTPA), an intravascular MR contrast agent, and projection MR imaging. J Comput Assist Tomogr 1989;13: 215-221.
13. Wang JC, Wikstrom MG, White DL, et al. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: Imaging characteristics in normal rat tissues. Radiology 1990;175:483-488.
14. Meyer D, Schaefer M, Chambon C, Beaute S. Paramagnetic dextrans as magnetic resonance blood pool tracers. Invest Radiol 1994;29:S90-S92.
15. Du Y, Parker DL, Davis WL, Blatter DD. Contrast-to-noise-ratio measurements in three-dimensional magnetic resonance angiography. Invest Radiol 1993;28:1004-1009.
16. Henkelman RM. Measurement of signal intensities in the presence of noise in MR images. Med Phys 1985;12:232-233.
17. Marchal G, Bosnians H, Van Fraeyenhoven L, et al. Intracranial vascular lesions: Optimization and clinical evaluation of three-dimensional time-of-flight MR angiography. Radiology 1990;175:443-448.
18. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994;191:155-164.
19. Canet E, Revel D, Forrat R, et al. Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI. Magn Reson Imaging 1993;11:1139-1145.
20. Shibata T, Weissleder R, Schaffer B, Shen T, Papisov M, Brady TS. Tissue relaxivities and detectability of monocrystalline iron oxides (abstract). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1992. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1992:1416.
21. Brasch RC. Rationale and applications for macromolecular Gd-based contrast agent. Magn Reson Med 1991;22:282-287.